Skip to content

Clinical trials

Hyperlipidemias trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Country / region: United States Clear all

334 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20025
20034
200419
200522
200616
200718
20089
200913
201016
201119
201213
201316
201412
201518
201616
20178
20188
20198
20207
202112
202210
20238
202417
202518
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed244
Recruiting22
Terminated22
Active, not recruiting15
Unknown status14
Withdrawn8
Not yet recruiting4
Enrolling by invitation4
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer21
Amgen14
Takeda11
Novartis Pharmaceuticals9
Esperion Therapeutics, Inc.8
AstraZeneca7
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7
Brigham and Women's Hospital6
Emory University6
University of Colorado, Denver6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias334
Hypertension88
Hypercholesterolemia70
Diabetes Mellitus67
Dyslipidemias58
Cardiovascular Diseases57
Obesity43
Diabetes Mellitus, Type 226
Atherosclerosis22
Coronary Artery Disease20

Trials

Showing 1 to 25 of 334. Each trial links to its page on Pharma Observatory.

234 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.